

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.01773184 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.01773184 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.65541040 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.65541040 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 6.17027111 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.10314467 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.92726398 |
| 8 | NADH metabolic process (GO:0006734) | 5.75153811 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.35946384 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.30390098 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.29026544 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.29026544 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.29026544 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.25416052 |
| 15 | fatty acid homeostasis (GO:0055089) | 5.21882105 |
| 16 | cysteine metabolic process (GO:0006534) | 5.20619923 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.06169774 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.02809421 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.98052316 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85324508 |
| 21 | lysine metabolic process (GO:0006553) | 4.72477739 |
| 22 | lysine catabolic process (GO:0006554) | 4.72477739 |
| 23 | diacylglycerol metabolic process (GO:0046339) | 4.71174238 |
| 24 | urea cycle (GO:0000050) | 4.68595988 |
| 25 | urea metabolic process (GO:0019627) | 4.68595988 |
| 26 | * acetyl-CoA metabolic process (GO:0006084) | 4.50516813 |
| 27 | bile acid metabolic process (GO:0008206) | 4.49975067 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.47155273 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.46432582 |
| 30 | triglyceride biosynthetic process (GO:0019432) | 4.44356163 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.42554608 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.39959028 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.39497564 |
| 34 | triglyceride catabolic process (GO:0019433) | 4.39142768 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.35707974 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.35676505 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.33073510 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.31476026 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.28597009 |
| 40 | acylglycerol biosynthetic process (GO:0046463) | 4.26480552 |
| 41 | neutral lipid biosynthetic process (GO:0046460) | 4.26480552 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.26381252 |
| 43 | protein carboxylation (GO:0018214) | 4.25723001 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25723001 |
| 45 | intestinal absorption (GO:0050892) | 4.25217040 |
| 46 | negative regulation of fibrinolysis (GO:0051918) | 4.23017467 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.22981697 |
| 48 | oxaloacetate metabolic process (GO:0006107) | 4.22283442 |
| 49 | neutral lipid catabolic process (GO:0046461) | 4.20474194 |
| 50 | acylglycerol catabolic process (GO:0046464) | 4.20474194 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 4.19503196 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.17550198 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.12061779 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.12061779 |
| 55 | regulation of protein activation cascade (GO:2000257) | 4.09996936 |
| 56 | regulation of fibrinolysis (GO:0051917) | 4.06826068 |
| 57 | * short-chain fatty acid metabolic process (GO:0046459) | 4.05394016 |
| 58 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.04450622 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.04271603 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 4.03648524 |
| 61 | glutamate metabolic process (GO:0006536) | 3.99007251 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 3.95927039 |
| 63 | reverse cholesterol transport (GO:0043691) | 3.91396989 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 3.90228658 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.90228658 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.90228658 |
| 67 | regulation of cholesterol storage (GO:0010885) | 3.88074859 |
| 68 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.86901007 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.85299410 |
| 70 | very long-chain fatty acid metabolic process (GO:0000038) | 3.84905007 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.84669878 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.84669878 |
| 73 | fatty acid oxidation (GO:0019395) | 3.84626591 |
| 74 | drug transmembrane transport (GO:0006855) | 3.83897614 |
| 75 | drug catabolic process (GO:0042737) | 3.83508578 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.82989979 |
| 77 | regulation of complement activation (GO:0030449) | 3.82752979 |
| 78 | biotin metabolic process (GO:0006768) | 3.80690998 |
| 79 | fatty acid catabolic process (GO:0009062) | 3.79212923 |
| 80 | lipid oxidation (GO:0034440) | 3.78895408 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.76942274 |
| 82 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.75641453 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.75309664 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.73959187 |
| 85 | triglyceride metabolic process (GO:0006641) | 3.73948570 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 3.73817631 |
| 87 | organic acid catabolic process (GO:0016054) | 3.73110162 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.73110162 |
| 89 | * thioester biosynthetic process (GO:0035384) | 3.73100949 |
| 90 | * acyl-CoA biosynthetic process (GO:0071616) | 3.73100949 |
| 91 | valine metabolic process (GO:0006573) | 3.72448825 |
| 92 | cellular glucuronidation (GO:0052695) | 3.72323898 |
| 93 | amine catabolic process (GO:0009310) | 3.70155935 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.70155935 |
| 95 | ketone body metabolic process (GO:1902224) | 3.69056776 |
| 96 | phospholipid efflux (GO:0033700) | 3.68706653 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.66653663 |
| 98 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.65021586 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.63792525 |
| 100 | carnitine shuttle (GO:0006853) | 3.63708532 |
| 101 | * ethanol oxidation (GO:0006069) | 3.63254955 |
| 102 | regulation of sequestering of triglyceride (GO:0010889) | 3.62938208 |
| 103 | * acyl-CoA metabolic process (GO:0006637) | 3.62722698 |
| 104 | * thioester metabolic process (GO:0035383) | 3.62722698 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.62050543 |
| 106 | bile acid and bile salt transport (GO:0015721) | 3.61825926 |
| 107 | linoleic acid metabolic process (GO:0043651) | 3.61329873 |
| 108 | fatty acid elongation (GO:0030497) | 3.61048445 |
| 109 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60648382 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59248651 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59248651 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58453893 |
| 113 | cofactor catabolic process (GO:0051187) | 3.58369086 |
| 114 | acylglycerol metabolic process (GO:0006639) | 3.55486527 |
| 115 | creatine metabolic process (GO:0006600) | 3.54452256 |
| 116 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.53891470 |
| 117 | cholesterol efflux (GO:0033344) | 3.52855875 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50589009 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 3.50434845 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.50302329 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49897014 |
| 122 | neutral lipid metabolic process (GO:0006638) | 3.49237848 |
| 123 | plasma lipoprotein particle assembly (GO:0034377) | 3.47700614 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 3.46172048 |
| 125 | carnitine metabolic process (GO:0009437) | 3.45802156 |
| 126 | glycine metabolic process (GO:0006544) | 3.44807447 |
| 127 | aldehyde catabolic process (GO:0046185) | 3.43863646 |
| 128 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.38487178 |
| 129 | angiotensin maturation (GO:0002003) | 3.38101659 |
| 130 | fructose metabolic process (GO:0006000) | 3.35423228 |
| 131 | fatty acid transmembrane transport (GO:1902001) | 3.29665410 |
| 132 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.29000522 |
| 133 | protein-lipid complex subunit organization (GO:0071825) | 3.26008277 |
| 134 | plasma lipoprotein particle organization (GO:0071827) | 3.25566068 |
| 135 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.17430048 |
| 136 | lipoprotein transport (GO:0042953) | 3.11864768 |
| 137 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.10299350 |
| 138 | epoxygenase P450 pathway (GO:0019373) | 3.09074260 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.08576243 |
| 140 | intestinal cholesterol absorption (GO:0030299) | 3.08103993 |
| 141 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00180718 |
| 142 | regulation of triglyceride metabolic process (GO:0090207) | 2.98152057 |
| 143 | positive regulation of lipid storage (GO:0010884) | 2.97002324 |
| 144 | glycerolipid catabolic process (GO:0046503) | 2.96989110 |
| 145 | proline biosynthetic process (GO:0006561) | 2.95925681 |
| 146 | regulation of apoptotic cell clearance (GO:2000425) | 2.93162109 |
| 147 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.86686322 |
| 148 | cholesterol homeostasis (GO:0042632) | 2.86187330 |
| 149 | lipoprotein metabolic process (GO:0042157) | 2.82565239 |
| 150 | sterol homeostasis (GO:0055092) | 2.81804383 |
| 151 | lipid storage (GO:0019915) | 2.80250679 |
| 152 | tricarboxylic acid cycle (GO:0006099) | 2.77553357 |
| 153 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77510167 |
| 154 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.76075017 |
| 155 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.75426049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31124541 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.17000764 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10016332 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84767823 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.68937451 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.73580921 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.03646274 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61925630 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.57622898 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.21565208 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57594839 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2065366 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91961674 |
| 14 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80782558 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78775125 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76620903 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73532928 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69148910 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62178316 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60654655 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57557011 |
| 22 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54426419 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.53770667 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52010623 |
| 25 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50357311 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48423334 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37437175 |
| 28 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28009899 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27201662 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26196514 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25979037 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21703182 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21696614 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21562272 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20883205 |
| 36 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19489766 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19125625 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18074490 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15112289 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14997303 |
| 41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14435899 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14214771 |
| 43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13951188 |
| 44 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13610178 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13223699 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11484767 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11381229 |
| 48 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.10699500 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09733782 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09187267 |
| 51 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08372530 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07316870 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06062903 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05491946 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05061754 |
| 56 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04597281 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04544728 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.04344906 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03772107 |
| 60 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02877510 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02352245 |
| 62 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02236791 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01804228 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00487551 |
| 65 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99137483 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99108279 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97895132 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97329407 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97099572 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96813708 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96384161 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95867439 |
| 73 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92785860 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91940646 |
| 75 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91723940 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91690226 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91690226 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90787691 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90317616 |
| 80 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89815876 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88226225 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88140430 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87725705 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87281456 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86511723 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86287732 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80357758 |
| 88 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79215403 |
| 89 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78174235 |
| 90 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77222308 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77075093 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74835236 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.70911953 |
| 94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70445049 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69929075 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69554231 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69462151 |
| 98 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67583586 |
| 99 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.66214228 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.65958890 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.64715767 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64646643 |
| 103 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64435253 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63561216 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63486528 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63015949 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62154695 |
| 108 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61347051 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61020886 |
| 110 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59245532 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59232964 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59130935 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.58537427 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57726222 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57567210 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.57362570 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.56549093 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56544694 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56479476 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56187489 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55329802 |
| 122 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55287671 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54561484 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.53105925 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.53008400 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52154537 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51072543 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50503738 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49965914 |
| 130 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49874440 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49744029 |
| 132 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.48905690 |
| 133 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48155872 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48118329 |
| 135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48061630 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47933817 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.47783115 |
| 138 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.47783115 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.47600137 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.47287589 |
| 141 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.47027517 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45462020 |
| 143 | NCOR_22424771_ChIP-Seq_293T_Human | 0.45415159 |
| 144 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.45079991 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44825593 |
| 146 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.44423161 |
| 147 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44196331 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43392490 |
| 149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.42599062 |
| 150 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.41772181 |
| 151 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.41444462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.87261147 |
| 2 | MP0005360_urolithiasis | 7.05063970 |
| 3 | MP0005365_abnormal_bile_salt | 5.66089425 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.60621299 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.70976997 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.93717842 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.50222762 |
| 8 | MP0003252_abnormal_bile_duct | 3.41790525 |
| 9 | MP0005332_abnormal_amino_acid | 3.01771446 |
| 10 | MP0003195_calcinosis | 2.93083201 |
| 11 | MP0009840_abnormal_foam_cell | 2.91532894 |
| 12 | MP0005083_abnormal_biliary_tract | 2.83623391 |
| 13 | MP0002118_abnormal_lipid_homeostasis | 2.40581367 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.31911500 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.22451760 |
| 16 | MP0000751_myopathy | 2.13381540 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.12281714 |
| 18 | MP0000609_abnormal_liver_physiology | 2.08472047 |
| 19 | MP0005670_abnormal_white_adipose | 1.91887765 |
| 20 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.85191942 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.78308823 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.77181493 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.75750713 |
| 24 | MP0001764_abnormal_homeostasis | 1.59499681 |
| 25 | MP0006138_congestive_heart_failure | 1.58174479 |
| 26 | MP0003868_abnormal_feces_composition | 1.56807995 |
| 27 | MP0005409_darkened_coat_color | 1.56115555 |
| 28 | MP0003186_abnormal_redox_activity | 1.54805239 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.53690089 |
| 30 | MP0003011_delayed_dark_adaptation | 1.53502200 |
| 31 | MP0004130_abnormal_muscle_cell | 1.51883295 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.47972532 |
| 33 | MP0005451_abnormal_body_composition | 1.42142115 |
| 34 | MP0003690_abnormal_glial_cell | 1.37913118 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.36954793 |
| 36 | MP0000604_amyloidosis | 1.34313405 |
| 37 | MP0003329_amyloid_beta_deposits | 1.33175559 |
| 38 | MP0004858_abnormal_nervous_system | 1.31488986 |
| 39 | MP0004272_abnormal_basement_membrane | 1.30520730 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.28723927 |
| 41 | MP0002971_abnormal_brown_adipose | 1.27444641 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.26822780 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.25759771 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.24040410 |
| 45 | MP0005330_cardiomyopathy | 1.20395323 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.19288068 |
| 47 | MP0005535_abnormal_body_temperature | 1.16928951 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.16652093 |
| 49 | MP0001661_extended_life_span | 1.16062719 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.15729528 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.14724002 |
| 52 | MP0009697_abnormal_copulation | 1.11412575 |
| 53 | MP0005647_abnormal_sex_gland | 1.10944192 |
| 54 | MP0004043_abnormal_pH_regulation | 1.09731474 |
| 55 | MP0000747_muscle_weakness | 1.09120460 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 1.08090244 |
| 57 | MP0008260_abnormal_autophagy | 1.07691327 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.07326597 |
| 59 | MP0000749_muscle_degeneration | 1.07111976 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.06696518 |
| 61 | MP0005334_abnormal_fat_pad | 1.04330538 |
| 62 | MP0003828_pulmonary_edema | 1.01522588 |
| 63 | MP0000598_abnormal_liver_morphology | 0.98616057 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.96773433 |
| 65 | MP0000678_abnormal_parathyroid_gland | 0.95761390 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.95249898 |
| 67 | MP0002254_reproductive_system_inflammat | 0.93647310 |
| 68 | MP0009763_increased_sensitivity_to | 0.92422422 |
| 69 | MP0005385_cardiovascular_system_phenoty | 0.91622055 |
| 70 | MP0001544_abnormal_cardiovascular_syste | 0.91622055 |
| 71 | MP0009764_decreased_sensitivity_to | 0.91353466 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.89665883 |
| 73 | MP0002269_muscular_atrophy | 0.88310296 |
| 74 | MP0003879_abnormal_hair_cell | 0.86108826 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.85942904 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.85739398 |
| 77 | MP0002972_abnormal_cardiac_muscle | 0.82418164 |
| 78 | MP0000920_abnormal_myelination | 0.82281751 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.80343775 |
| 80 | MP0004185_abnormal_adipocyte_glucose | 0.80258185 |
| 81 | MP0001756_abnormal_urination | 0.80002866 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.78543113 |
| 83 | MP0004233_abnormal_muscle_weight | 0.78266975 |
| 84 | MP0000343_altered_response_to | 0.78039996 |
| 85 | MP0008469_abnormal_protein_level | 0.77492902 |
| 86 | MP0002106_abnormal_muscle_physiology | 0.77321450 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.76664692 |
| 88 | MP0000858_altered_metastatic_potential | 0.76650189 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.76203096 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.75113833 |
| 91 | MP0005448_abnormal_energy_balance | 0.74864885 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.73007784 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.72856373 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.71783473 |
| 95 | MP0005501_abnormal_skin_physiology | 0.71382225 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.70404109 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.70377497 |
| 98 | MP0005164_abnormal_response_to | 0.70343096 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.70268980 |
| 100 | MP0000249_abnormal_blood_vessel | 0.70135281 |
| 101 | MP0005275_abnormal_skin_tensile | 0.69931146 |
| 102 | MP0004947_skin_inflammation | 0.69852315 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.69672162 |
| 104 | MP0002132_abnormal_respiratory_system | 0.69398569 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.68353703 |
| 106 | MP0004147_increased_porphyrin_level | 0.68041730 |
| 107 | MP0002822_catalepsy | 0.66509161 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.65404415 |
| 109 | MP0005408_hypopigmentation | 0.63289237 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.62983873 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.61902439 |
| 112 | MP0009115_abnormal_fat_cell | 0.60651128 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.59958453 |
| 114 | MP0002970_abnormal_white_adipose | 0.59207869 |
| 115 | MP0005266_abnormal_metabolism | 0.59172767 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.58000005 |
| 117 | MP0003953_abnormal_hormone_level | 0.55876689 |
| 118 | MP0003075_altered_response_to | 0.55523956 |
| 119 | MP0003705_abnormal_hypodermis_morpholog | 0.55126585 |
| 120 | MP0008872_abnormal_physiological_respon | 0.54104009 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.53135386 |
| 122 | MP0008874_decreased_physiological_sensi | 0.53026956 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 0.52091050 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.51601509 |
| 125 | MP0003724_increased_susceptibility_to | 0.48638935 |
| 126 | MP0002796_impaired_skin_barrier | 0.47736369 |
| 127 | MP0003959_abnormal_lean_body | 0.47347783 |
| 128 | MP0003633_abnormal_nervous_system | 0.45522988 |
| 129 | MP0002168_other_aberrant_phenotype | 0.44542391 |
| 130 | MP0005452_abnormal_adipose_tissue | 0.43455955 |
| 131 | MP0002090_abnormal_vision | 0.42701098 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.42375059 |
| 133 | MP0001881_abnormal_mammary_gland | 0.42334412 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.41260576 |
| 135 | MP0005395_other_phenotype | 0.38905102 |
| 136 | MP0004885_abnormal_endolymph | 0.35701312 |
| 137 | MP0003631_nervous_system_phenotype | 0.35515396 |
| 138 | MP0004381_abnormal_hair_follicle | 0.33927514 |
| 139 | MP0006082_CNS_inflammation | 0.33731420 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.33238818 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.33065142 |
| 142 | MP0008873_increased_physiological_sensi | 0.32965198 |
| 143 | MP0003632_abnormal_nervous_system | 0.31244568 |
| 144 | MP0005166_decreased_susceptibility_to | 0.30937434 |
| 145 | MP0004142_abnormal_muscle_tone | 0.29939232 |
| 146 | MP0002229_neurodegeneration | 0.28069492 |
| 147 | MP0002295_abnormal_pulmonary_circulatio | 0.27902456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.61033300 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.47406857 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.95303249 |
| 4 | Xanthomatosis (HP:0000991) | 5.77638193 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.37102784 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.11134201 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 5.09768658 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.01758719 |
| 9 | Hyperglycinuria (HP:0003108) | 4.79450132 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.68051558 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.68051558 |
| 12 | Hyperammonemia (HP:0001987) | 4.62263861 |
| 13 | Hyperglycinemia (HP:0002154) | 4.52983810 |
| 14 | Ketosis (HP:0001946) | 4.51408425 |
| 15 | Complement deficiency (HP:0004431) | 4.29423163 |
| 16 | Epidermoid cyst (HP:0200040) | 4.24285300 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.21288409 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.96740802 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.87707298 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.84703677 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.84411139 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.77518012 |
| 23 | Joint hemorrhage (HP:0005261) | 3.73579169 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.72623161 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.70247246 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.66956717 |
| 27 | Ketoacidosis (HP:0001993) | 3.65002467 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.60765050 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.60269743 |
| 30 | Exercise-induced myalgia (HP:0003738) | 3.59369329 |
| 31 | Fat malabsorption (HP:0002630) | 3.46956523 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39332413 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.23498908 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.10730190 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.10005440 |
| 36 | Dicarboxylic aciduria (HP:0003215) | 3.10005440 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.08711803 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.08550141 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.04601606 |
| 40 | Polycythemia (HP:0001901) | 2.97670286 |
| 41 | Metabolic acidosis (HP:0001942) | 2.94661793 |
| 42 | Abnormality of complement system (HP:0005339) | 2.92960043 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.91076365 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86833118 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85260801 |
| 46 | Gout (HP:0001997) | 2.84820008 |
| 47 | Glomerulonephritis (HP:0000099) | 2.83397747 |
| 48 | Lethargy (HP:0001254) | 2.80184140 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.73629673 |
| 50 | Ileus (HP:0002595) | 2.67341432 |
| 51 | Cerebral edema (HP:0002181) | 2.64169132 |
| 52 | Flat acetabular roof (HP:0003180) | 2.63529753 |
| 53 | Steatorrhea (HP:0002570) | 2.62852821 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.62115855 |
| 55 | Vascular calcification (HP:0004934) | 2.58846766 |
| 56 | Increased connective tissue (HP:0009025) | 2.56883785 |
| 57 | Acanthocytosis (HP:0001927) | 2.56058635 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.55314969 |
| 59 | Skin nodule (HP:0200036) | 2.54004148 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.52434623 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51929800 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50354740 |
| 63 | Myocardial infarction (HP:0001658) | 2.49961230 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.47495480 |
| 65 | Myopathic facies (HP:0002058) | 2.47463259 |
| 66 | Cholecystitis (HP:0001082) | 2.41651409 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.41651409 |
| 68 | Irritability (HP:0000737) | 2.41085573 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.40305458 |
| 70 | Vomiting (HP:0002013) | 2.39342310 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.37417007 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.37417007 |
| 73 | Cholelithiasis (HP:0001081) | 2.36669920 |
| 74 | Brushfield spots (HP:0001088) | 2.35634703 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.33716484 |
| 76 | Alkalosis (HP:0001948) | 2.33290384 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 2.30291641 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.29928029 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.29922351 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.29465222 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 2.29007026 |
| 82 | Acanthosis nigricans (HP:0000956) | 2.28691578 |
| 83 | Abnormality of carpal bone ossification (HP:0006257) | 2.28121624 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.27958121 |
| 85 | Type 1 muscle fiber predominance (HP:0003803) | 2.27134231 |
| 86 | Nemaline bodies (HP:0003798) | 2.26566226 |
| 87 | Amyloidosis (HP:0011034) | 2.25514007 |
| 88 | Nausea (HP:0002018) | 2.24523229 |
| 89 | Spontaneous abortion (HP:0005268) | 2.24194633 |
| 90 | Difficulty running (HP:0009046) | 2.23047532 |
| 91 | Axonal loss (HP:0003447) | 2.22470601 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.22122217 |
| 93 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.22045257 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.20713295 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.19031107 |
| 96 | Pancreatitis (HP:0001733) | 2.16944501 |
| 97 | Hyperuricemia (HP:0002149) | 2.15883624 |
| 98 | Increased purine levels (HP:0004368) | 2.15883624 |
| 99 | Spastic diplegia (HP:0001264) | 2.13304699 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.11928264 |
| 101 | Enlarged kidneys (HP:0000105) | 2.10275862 |
| 102 | Neonatal onset (HP:0003623) | 2.08709885 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 2.06982896 |
| 104 | Muscle stiffness (HP:0003552) | 2.05631515 |
| 105 | Rickets (HP:0002748) | 2.03760443 |
| 106 | Nephritis (HP:0000123) | 2.03756335 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 2.02889569 |
| 108 | Glycosuria (HP:0003076) | 2.02889569 |
| 109 | Malnutrition (HP:0004395) | 2.01559706 |
| 110 | Abnormality of glycolysis (HP:0004366) | 2.01332869 |
| 111 | Increased serum pyruvate (HP:0003542) | 2.01332869 |
| 112 | Hypertriglyceridemia (HP:0002155) | 2.01295072 |
| 113 | Neurofibrillary tangles (HP:0002185) | 2.00765158 |
| 114 | Late onset (HP:0003584) | 2.00118022 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.99997700 |
| 116 | Mitral stenosis (HP:0001718) | 1.99946391 |
| 117 | Renal cortical cysts (HP:0000803) | 1.99713741 |
| 118 | Neck muscle weakness (HP:0000467) | 1.99644221 |
| 119 | Breech presentation (HP:0001623) | 1.98956206 |
| 120 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97746975 |
| 121 | Reticulocytosis (HP:0001923) | 1.94531862 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 1.93371274 |
| 123 | Distal lower limb amyotrophy (HP:0008944) | 1.92260423 |
| 124 | Opisthotonus (HP:0002179) | 1.89818832 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89738713 |
| 126 | Cerebral aneurysm (HP:0004944) | 1.89082051 |
| 127 | Purpura (HP:0000979) | 1.88773764 |
| 128 | Methylmalonic aciduria (HP:0012120) | 1.88638607 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88367524 |
| 130 | Oligomenorrhea (HP:0000876) | 1.87266185 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.86700560 |
| 132 | Myoglobinuria (HP:0002913) | 1.85253090 |
| 133 | Growth hormone excess (HP:0000845) | 1.85065715 |
| 134 | Back pain (HP:0003418) | 1.84182336 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.83082270 |
| 136 | Acute hepatic failure (HP:0006554) | 1.82441286 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.81664237 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.80562343 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.79306874 |
| 140 | Stridor (HP:0010307) | 1.76191031 |
| 141 | Thin bony cortex (HP:0002753) | 1.76083864 |
| 142 | Hyporeflexia of lower limbs (HP:0002600) | 1.75915506 |
| 143 | Muscle fiber splitting (HP:0003555) | 1.75335135 |
| 144 | Ventricular tachycardia (HP:0004756) | 1.75196956 |
| 145 | Abnormal ossification of hand bones (HP:0005921) | 1.74114172 |
| 146 | Esophageal varix (HP:0002040) | 1.71214039 |
| 147 | Mucopolysacchariduria (HP:0008155) | 1.68595303 |
| 148 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68595303 |
| 149 | EMG: myopathic abnormalities (HP:0003458) | 1.67809134 |
| 150 | Cupped ribs (HP:0000887) | 1.65809513 |
| 151 | Sudden death (HP:0001699) | 1.65365657 |
| 152 | Dysostosis multiplex (HP:0000943) | 1.64225815 |
| 153 | Widely patent fontanelles and sutures (HP:0004492) | 1.64060865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.11608084 |
| 2 | SIK1 | 4.18619255 |
| 3 | FGFR4 | 3.26230392 |
| 4 | CAMK1D | 2.81376845 |
| 5 | STK39 | 2.75202109 |
| 6 | INSRR | 2.51839737 |
| 7 | OXSR1 | 2.45757852 |
| 8 | WNK4 | 2.42085679 |
| 9 | ERN1 | 2.39587044 |
| 10 | EPHB1 | 2.25285425 |
| 11 | CAMK1G | 2.24072239 |
| 12 | EEF2K | 2.17193410 |
| 13 | PRPF4B | 2.15735261 |
| 14 | PDK4 | 2.05285997 |
| 15 | PDK3 | 2.05285997 |
| 16 | EPHA2 | 2.02824394 |
| 17 | TTN | 2.00692583 |
| 18 | TRIB3 | 1.93945104 |
| 19 | MST1R | 1.84768933 |
| 20 | ERBB4 | 1.82436527 |
| 21 | FGFR2 | 1.81349502 |
| 22 | MAP2K4 | 1.70860413 |
| 23 | PINK1 | 1.69428962 |
| 24 | RIPK4 | 1.60858784 |
| 25 | PDGFRA | 1.56593816 |
| 26 | PRKAA2 | 1.53744218 |
| 27 | TAOK3 | 1.50664555 |
| 28 | DAPK2 | 1.43827917 |
| 29 | MAP3K6 | 1.39564953 |
| 30 | DDR2 | 1.35931829 |
| 31 | TESK1 | 1.29581683 |
| 32 | EPHB2 | 1.26468571 |
| 33 | MAP3K1 | 1.22798137 |
| 34 | MAPK11 | 1.22239055 |
| 35 | MYLK | 1.22188778 |
| 36 | MET | 1.21905644 |
| 37 | PIK3CG | 1.21033334 |
| 38 | SGK223 | 1.20897684 |
| 39 | SGK494 | 1.20897684 |
| 40 | MAP3K7 | 1.19606014 |
| 41 | PDK2 | 1.18479041 |
| 42 | PRKG2 | 1.16225770 |
| 43 | LATS2 | 1.09433607 |
| 44 | WNK3 | 1.07746159 |
| 45 | MAPKAPK3 | 1.06898883 |
| 46 | JAK2 | 1.04917590 |
| 47 | PDPK1 | 1.04514883 |
| 48 | ABL2 | 1.02018102 |
| 49 | EPHA4 | 1.01706252 |
| 50 | PKN1 | 0.97155663 |
| 51 | TGFBR2 | 0.96629430 |
| 52 | PKN2 | 0.95327110 |
| 53 | PBK | 0.93686617 |
| 54 | TYK2 | 0.92506479 |
| 55 | SMG1 | 0.92096182 |
| 56 | PAK4 | 0.91755851 |
| 57 | PRKAA1 | 0.90463194 |
| 58 | FLT3 | 0.90106554 |
| 59 | MAP3K3 | 0.88978452 |
| 60 | CDC42BPA | 0.88554144 |
| 61 | ZAP70 | 0.87577120 |
| 62 | LMTK2 | 0.84477513 |
| 63 | MAP3K13 | 0.83661298 |
| 64 | JAK1 | 0.82596896 |
| 65 | PHKG1 | 0.81937043 |
| 66 | PHKG2 | 0.81937043 |
| 67 | PRKACG | 0.80194866 |
| 68 | PRKCQ | 0.79172275 |
| 69 | ICK | 0.78898610 |
| 70 | PTK6 | 0.76572795 |
| 71 | FRK | 0.76372934 |
| 72 | CAMK2G | 0.76249771 |
| 73 | TAOK2 | 0.75833056 |
| 74 | PDK1 | 0.73876711 |
| 75 | PRKCZ | 0.73846758 |
| 76 | CSNK1G1 | 0.72167864 |
| 77 | MAPK12 | 0.72066703 |
| 78 | NTRK1 | 0.71732997 |
| 79 | TIE1 | 0.71716566 |
| 80 | MTOR | 0.71652602 |
| 81 | GSK3A | 0.71288889 |
| 82 | NEK9 | 0.71041694 |
| 83 | GRK6 | 0.70410698 |
| 84 | RIPK1 | 0.67038545 |
| 85 | FER | 0.66108046 |
| 86 | MAPK15 | 0.66039367 |
| 87 | CDK6 | 0.65945460 |
| 88 | ARAF | 0.65798110 |
| 89 | BMX | 0.64949085 |
| 90 | CSNK1G2 | 0.63118372 |
| 91 | MAP3K11 | 0.62898719 |
| 92 | CSNK1G3 | 0.62618951 |
| 93 | TBK1 | 0.62396028 |
| 94 | PAK3 | 0.62254594 |
| 95 | MAPK4 | 0.61361579 |
| 96 | SGK3 | 0.61107095 |
| 97 | ERBB2 | 0.60417245 |
| 98 | TYRO3 | 0.59032832 |
| 99 | WNK1 | 0.56025741 |
| 100 | IRAK2 | 0.55924820 |
| 101 | RET | 0.55741160 |
| 102 | MARK2 | 0.55455339 |
| 103 | DYRK1B | 0.53882605 |
| 104 | SCYL2 | 0.53470578 |
| 105 | CSNK1A1L | 0.53082132 |
| 106 | TESK2 | 0.52486775 |
| 107 | PIM2 | 0.52045281 |
| 108 | DMPK | 0.51161775 |
| 109 | MATK | 0.50428396 |
| 110 | CSK | 0.50407651 |
| 111 | ACVR1B | 0.50310711 |
| 112 | JAK3 | 0.49994615 |
| 113 | TRPM7 | 0.49754079 |
| 114 | MAP2K6 | 0.49226422 |
| 115 | IRAK1 | 0.49183412 |
| 116 | NME2 | 0.47975583 |
| 117 | KSR2 | 0.45868171 |
| 118 | PRKCH | 0.45148797 |
| 119 | IGF1R | 0.44867950 |
| 120 | FGFR3 | 0.44630754 |
| 121 | MAP3K14 | 0.44120278 |
| 122 | MAP2K1 | 0.43972543 |
| 123 | PRKD1 | 0.43946763 |
| 124 | RAF1 | 0.42886059 |
| 125 | TAOK1 | 0.41999239 |
| 126 | LRRK2 | 0.41610320 |
| 127 | IRAK3 | 0.41552934 |
| 128 | MAP3K2 | 0.41490256 |
| 129 | KDR | 0.41279552 |
| 130 | SGK2 | 0.41091568 |
| 131 | MAPK7 | 0.40349438 |
| 132 | OBSCN | 0.39114502 |
| 133 | PTK2 | 0.38969693 |
| 134 | MAPKAPK5 | 0.38718257 |
| 135 | MAP3K4 | 0.38021548 |
| 136 | CDK12 | 0.35635889 |
| 137 | RPS6KA2 | 0.35337137 |
| 138 | SRC | 0.34796518 |
| 139 | PIK3CA | 0.34678683 |
| 140 | MAP3K8 | 0.34495816 |
| 141 | MAP2K3 | 0.34417486 |
| 142 | EPHA3 | 0.34191039 |
| 143 | PRKACA | 0.32429099 |
| 144 | LATS1 | 0.30303996 |
| 145 | ITK | 0.29546108 |
| 146 | PRKCA | 0.29147512 |
| 147 | IKBKE | 0.28473451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.75965604 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35032070 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.07514779 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.02365154 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.80025367 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74517240 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68836591 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66331197 |
| 9 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.59018789 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57426872 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.56637831 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49421124 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.45792038 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31512063 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.24961825 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.20455540 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16917829 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07673863 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.02690216 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99599543 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95691436 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.93095025 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82138676 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78850497 |
| 25 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73665753 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71314576 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69966554 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69898189 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66139366 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61937236 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.58656177 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55260358 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50958418 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48112327 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47561508 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43209354 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.43118045 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38107244 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35552257 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28897800 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27838252 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27368275 |
| 43 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.26985214 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20210468 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20115306 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19710690 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17769193 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.14590954 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08876399 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08710261 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06983654 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05981049 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04784267 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03176371 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00038254 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98052254 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95432431 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94655452 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88981555 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85524036 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80039024 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76604490 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.74374350 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73229505 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69878790 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66074901 |
| 67 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65890445 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64721689 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62854653 |
| 70 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50481562 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47460321 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45609987 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35849800 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33753634 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.32388171 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.31435779 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30784143 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30157945 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.26938795 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.24617437 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23694334 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21876746 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20367401 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.18282494 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17733507 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.16954076 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15399333 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15261035 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.15250246 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15188679 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14860875 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13252829 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12730457 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12374592 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12088367 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11068483 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09622538 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07195434 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.06267002 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03600733 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1979468 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1933640 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1919386 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1906367 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1875474 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1814827 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1724402 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1718196 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1572499 |
| 110 | Lysosome_Homo sapiens_hsa04142 | -0.1536184 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1294859 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1135849 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1117872 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | -0.1023462 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0782492 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0721655 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0089918 |

